We are live on ! Find out more
HRMY icon

Harmony Biosciences

326 hedge funds and large institutions have $1.87B invested in Harmony Biosciences in 2025 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 123 increasing their positions, 110 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 29

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

61% more capital inflows, than outflows

Capital inflows: $247M | Capital outflows: $154M

55% more call options, than puts

Call options by funds: $11.9M | Put options by funds: $7.68M

12% more repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 110

10% more funds holding

Funds holding: 297 → 326 (+29)

4.59% more ownership

Funds ownership: 82.38% → 86.97% (+4.6%)

Holders
326
Holders Change
+29
Holders Change %
+9.76%
% of All Funds
3.92%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.06%
New
60
Increased
123
Reduced
110
Closed
29
Calls
$11.9​M
Puts
$7.68​M
Net Calls
+$4.19​M
Net Calls Change
-⁠$17.7​M

HRMY Hedge Fund Activity: Q4 2025 in Review

326 of the 8,319 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q4 2025, worth a combined $1.87B — up 43% from $1.31B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new HRMY positions and 29 closed out — a net gain of 31 holders — while 123 added to existing stakes and 110 trimmed.

The largest buyer was SG Americas Securities, adding an estimated $30.9M. The largest seller was Valor Management, cutting an estimated $37.8M.

  • 326 institutional investors held Harmony Biosciences (HRMY) as of Q4 2025, up from 297 in Q3 2025.
  • Funds reported $1.87B of Harmony Biosciences stock for Q4 2025, up 43% quarter-over-quarter.
  • 60 funds opened new Harmony Biosciences positions in Q4 2025 and 29 closed out, a net change of +31 holders.
  • The largest Harmony Biosciences buyer in Q4 2025 was SG Americas Securities, an estimated $30.9M added.
  • The largest Harmony Biosciences seller in Q4 2025 was Valor Management, an estimated $37.8M sold.

Based on aggregated 13F filings for Q4 2025.